Showing 1 - 10 of 19
Persistent link: https://www.econbiz.de/10001376955
Persistent link: https://www.econbiz.de/10011545151
Persistent link: https://www.econbiz.de/10012108208
Persistent link: https://www.econbiz.de/10001825856
Persistent link: https://www.econbiz.de/10001852714
Persistent link: https://www.econbiz.de/10002685794
Persistent link: https://www.econbiz.de/10008796187
We examine the role of consumption externalities in the demand for pharmaceuticals at both the brand level and over a therapeutic class of drugs. These effects emerge when use of a drug by others affects its value, and/or conveys information abut efficacy and safety to patients and physicians....
Persistent link: https://www.econbiz.de/10012470978
We examine the role of network effects in the demand for pharmaceuticals at both the brand level and for a therapeutic class of drugs. These effects emerge when use of a drug by others conveys information about its efficacy and safety to patients and physicians. This can lead to herd behavior...
Persistent link: https://www.econbiz.de/10012471776
We quantify the impact of scientific grant funding at the National Institutes of Health (NIH) on patenting by pharmaceutical and biotechnology firms. Our paper makes two contributions. First, we use newly constructed bibliometric data to develop a method for flexibly linking specific grant...
Persistent link: https://www.econbiz.de/10013029543